Press release
Key Companies Leading Innovation and Growth in the Bioinformatics Sector of the In-Vitro Diagnostics (IVD) Testing Market
Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
Anticipated Market Size and Growth of Bioinformatics in In-Vitro Diagnostics Testing
The market for bioinformatics used in in-vitro diagnostics (IVD) testing is forecasted to reach $133.49 billion by 2030, with a compound annual growth rate (CAGR) of 6.0%. This growth is primarily propelled by a rising demand for precision diagnostics and the broadening application of personalized medicine. Additional factors supporting this expansion include increased investments in AI-powered diagnostic platforms, a growing reliance on cloud-based diagnostic analytics, and expanding regulatory support for digital diagnostic tools. Emerging trends contributing to this trajectory feature more widespread use of AI-driven diagnostic interpretation software, adoption of cloud-enabled bioinformatics platforms in IVD, integration of molecular with clinical datasets, development of companion diagnostics analytics, and a stronger emphasis on real-time diagnostic data processing.
Download a free sample of the bioinformatics in in-vitro diagnostics (ivd) testing market report:
https://www.thebusinessresearchcompany.com/report/bioinformatics-in-in-vitro-diagnostics-ivd-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Players Driving the Bioinformatics in IVD Testing Industry
Several major corporations play a pivotal role in this market, including Illumina Inc, Thermo Fisher Scientific Inc, QIAGEN N.V, Agilent Technologies Inc, PerkinElmer Inc, Roche Holding AG, BGI Genomics Co Ltd, DNAnexus Inc, Seven Bridges Genomics Inc, Dassault Systèmes SE (BIOVIA), Genedata AG, Partek Inc, Data4Cure Inc, Ontoforce NV, Geneious (Biomatters), SoftGenetics LLC, Eagle Genomics Ltd, Wuxi NextCODE Genomics, Bio-Rad Laboratories Inc, and Eurofins Scientific SE. These companies are instrumental in advancing bioinformatics tools and diagnostic solutions within the IVD space.
Recent Industry Collaborations Highlighting Innovation
In a notable development in September 2024, QIAGEN N.V., a molecular diagnostics company based in Germany, partnered with US pharmaceutical firm Eli Lilly and Company to develop the first in-vitro diagnostic test for APOE genotyping related to Alzheimer's disease. This collaboration utilizes QIAGEN's QIAstat-Dx platform and represents a significant step in applying bioinformatics to neurodegenerative disease diagnosis. Eli Lilly's expertise in IVD testing strengthens this joint effort, reflecting a growing trend of strategic partnerships aimed at expanding clinical diagnostic capabilities.
The bioinformatics sector within the in-vitro diagnostics (IVD) testing field is on the brink of substantial growth, fueled by advances in technology and increased demand for precision medicine. As healthcare continues to evolve, this market is set to expand significantly, driven by innovations that enhance diagnostic accuracy and efficiency. Let's explore the projected market size, key players, influential trends, and segmentation details shaping this promising industry.
Anticipated Market Size and Growth of Bioinformatics in In-Vitro Diagnostics Testing
The market for bioinformatics used in in-vitro diagnostics (IVD) testing is forecasted to reach $133.49 billion by 2030, with a compound annual growth rate (CAGR) of 6.0%. This growth is primarily propelled by a rising demand for precision diagnostics and the broadening application of personalized medicine. Additional factors supporting this expansion include increased investments in AI-powered diagnostic platforms, a growing reliance on cloud-based diagnostic analytics, and expanding regulatory support for digital diagnostic tools. Emerging trends contributing to this trajectory feature more widespread use of AI-driven diagnostic interpretation software, adoption of cloud-enabled bioinformatics platforms in IVD, integration of molecular with clinical datasets, development of companion diagnostics analytics, and a stronger emphasis on real-time diagnostic data processing.
Download a free sample of the bioinformatics in in-vitro diagnostics (ivd) testing market report:
https://www.thebusinessresearchcompany.com/report/bioinformatics-in-in-vitro-diagnostics-ivd-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Players Driving the Bioinformatics in IVD Testing Industry
Several major corporations play a pivotal role in this market, including Illumina Inc, Thermo Fisher Scientific Inc, QIAGEN N.V, Agilent Technologies Inc, PerkinElmer Inc, Roche Holding AG, BGI Genomics Co Ltd, DNAnexus Inc, Seven Bridges Genomics Inc, Dassault Systèmes SE (BIOVIA), Genedata AG, Partek Inc, Data4Cure Inc, Ontoforce NV, Geneious (Biomatters), SoftGenetics LLC, Eagle Genomics Ltd, Wuxi NextCODE Genomics, Bio-Rad Laboratories Inc, and Eurofins Scientific SE. These companies are instrumental in advancing bioinformatics tools and diagnostic solutions within the IVD space.
Recent Industry Collaborations Highlighting Innovation
In a notable development in September 2024, QIAGEN N.V., a molecular diagnostics company based in Germany, partnered with US pharmaceutical firm Eli Lilly and Company to develop the first in-vitro diagnostic test for APOE genotyping related to Alzheimer's disease. This collaboration utilizes QIAGEN's QIAstat-Dx platform and represents a significant step in applying bioinformatics to neurodegenerative disease diagnosis. Eli Lilly's expertise in IVD testing strengthens this joint effort, reflecting a growing trend of strategic partnerships aimed at expanding clinical diagnostic capabilities.
Emerging Developments Shaping the Future of Bioinformatics in IVD Testing
Innovation continues to drive progress in related medical technologies, such as catheters, which influence diagnostic procedures. For example, companies are focusing on atraumatic tracking techniques that reduce trauma during biological or physical monitoring. An illustration of this is Route 92 Medical, Inc., a US-based manufacturer, which introduced in July 2024 the FreeClimb 88 Catheter System. The device is FDA 510(k)-cleared and designed for smooth navigation through complex neurovascular structures. Its features include 125 cm and 132 cm lengths, a soft tapered tip to minimize the "ledge effect," and enhanced clinical usability by simplifying setup and optimizing vessel size compatibility for better flow control.
How the Bioinformatics in IVD Testing Market Is Structured by Type, Application, and Region
This market is segmented by several key categories:
1) Component: Hardware and Software
2) Type of Test: Blood-Based Tests and Tissue-Based Tests
3) Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, and Other Applications
Further subcategories under components include:
- Hardware: Analyzers, Laboratory Equipment, Data Storage Devices, Sensors and Detectors, Workstations and Data Processing Hardware
- Software: Bioinformatics Platforms, Data Management and Integration Software, Analytics and Interpretation Software, Cloud-Based Software Solutions, AI-Based Diagnostic Software
This detailed classification provides insight into the diverse technologies and applications driving the bioinformatics sector within IVD testing globally.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Companies Leading Innovation and Growth in the Bioinformatics Sector of the In-Vitro Diagnostics (IVD) Testing Market here
News-ID: 4462125 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Gastric Cancer Marke …
The gastric cancer market is poised for substantial expansion in the coming years, driven by significant advancements in medical technologies and growing awareness about early detection and treatment options. As the focus sharpens on personalized therapies and comprehensive cancer care, this sector is set to experience dynamic growth through 2030.
Projected Growth Trajectory of the Gastric Cancer Market
The size of the gastric cancer market is anticipated to increase rapidly, reaching…
Leading Companies Advancing Innovation and Growth in the Food Allergen Testing M …
The food allergen testing sector is poised for remarkable expansion as concerns about food safety and quality continue to rise worldwide. Increasingly stringent regulations, advancements in testing technology, and growing global food trade are all contributing to a surge in demand for precise and rapid allergen detection methods. Below, we delve into the market's size projections, key players, emerging trends, and segmentation to understand this fast-evolving industry better.
Projected Growth and…
Global Drivers Analysis: The Rapid Evolution of the Flow Cytometry Market in Onc …
An in-depth look at the flow cytometry market reveals substantial potential in oncology and immunology applications. This field is rapidly evolving, driven by breakthroughs in diagnostics and therapeutic approaches, setting the stage for significant market expansion in the coming years. Below is a detailed examination of the market size, key players, influential trends, and segmentation shaping this promising industry.
Projected Market Growth for Flow Cytometry in Oncology and Immunology
The flow…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Fitn …
The fitness tracker market is set for significant expansion over the coming years, driven by technological advancements and growing consumer interest in health and wellness. As wearable technology becomes more sophisticated and integrated with AI, this sector is poised to experience remarkable growth through 2030. Here is an overview of the market size predictions, key players, emerging trends, and segmentation details shaping the future of the fitness tracker industry.
Projected Growth…
More Releases for IVD
Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025?
The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32…
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology.
Every possible effort has been taken while researching and analysing…
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of…
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The IVD research report also provides insights of different regions that are contributing market growth.…
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688
The report provides a…
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256
The Asia-Pacific IVD market is…
